- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
November 9th, 2005
A novel medication called a nanoviricide, being developed by Westhaven, Connecticut-based NanoViricides, Inc, is likely to prove much more efficacious in treating patients infected by the deadly Avian flu than current favourites like oseltamivir (TamiFlu) of Roche and zanamivir (Relenza) of GlaxoSmithKline.
The key intellectual property on which the new drug is based is a flexible nanomaterial that contains an encapsulated active pharmaceutical ingredient and, using a ligand, targets it to a specific type of virus.
|Related News Press|
Designing ultrasound tools with Lego-like proteins August 29th, 2016
50 years after the release of the film 'Fantastic Voyage,' science upstages fiction: Science upstages fiction with nanorobotic agents designed to travel in the human body to treat cancer August 25th, 2016
Graphene under pressure August 26th, 2016
Semblant to Present at China Mobile Manufacturing Forum 2016 August 25th, 2016
Meteorite impact on a nano scale August 29th, 2016